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Abstract
Background: Paragangliomas (PGs) are neuroendocrine tumors derived embryonically from the neural crest cells of
the autonomic nervous system. Approximately 3 % of all paragangliomas occur in the head and neck area. Head
and neck paragangliomas (HNPGs) are rare and highly vascularized tumors, the majority of which are benign.
Multiple HNPGs with hepatic paraganglioma are exceedingly rare.
Case presentation: We report a 59-year-old male patient with a 40-year history of an enlarged mass at the right
side of the neck and two months of epigastric discomfort. Neck physical examination revealed a 6 × 6 cm, ovoid,
firm mass on the right side of the neck. A pre-contrast computed tomography (CT) scan of the head and neck
revealed bilateral heterogeneous soft tissue masses at the bifurcation of the carotid artery with indistinct border,
the size of which was 2.4 cm × 2.6 cm on the left and 5.4 cm × 4.3 cm on the right. The lesions were intensely and
heterogeneously enhanced with the internal and external carotid arteries surrounded and pushed anteriorly after
contrast administration. Magnetic resonance imaging (MRI) showed a hyperintense signal on T2 weighted images
compared to the surrounding muscle tissue and an intense contrast enhancement on T1 weighted images. Digital
subtraction angiography (DSA) exhibited a highly vascularized masses that occupied and deformed both sides of
the carotid bifurcation. As for the hepatic mass, non-contrasted CT imaging of the upper abdomen showed a
6.1 cm × 5.5 cm × 5.8 cm low density mass in the liver with indistinct border. On late arterial phase, the mass
showed slight enhancement with an enlarged hepatic artery pushed around the lesion. MR imaging of the lesion in
the liver demonstrated low signal intensity on T1 weighted images but heterogeneous high signal intensity on T2
weighted images. On diffusion weighted images, the mass showed high signal intensity whereas low signal
intensity was seen on the image of apparent diffusion coefficient (ADC). Moreover, the contrast-enhanced MRI
showed that the lesion was intensely but heterogeneously enhanced.
Conclusion: Multiple HNPGs with hepatic paraganglioma are exceedingly rare. Advanced medical imaging
modalities such as ultrasound (US), CT, MR, DSA and 123I-metaiodobenzylguanidine (123I-MIBG) are helpful in the
evaluation of the patients with PGs. Increased awareness of their concomitant occurrence and familiarity with their
characteristic features are critical for clinicians and radiologists to avoid diagnostic and therapeutic pitfalls and to
facilitate the early diagnosis.
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Background
Paragangliomas (PGs), representing 0.012 % of all tumors,
are rare and mostly benign neoplasms that originate from
the neuroendocrine tissue along the paravertebral axis and
thus may develop at various body sites [1–3]. PGs in head
and neck account for about 0.6 % of all head and neck tu-
mors, and the most anatomically prevalent sites found
within the head and neck region are the carotid body,
jugular body, along the glossopharyngeal nerve and its
tympanic branch, and the vagus nerve [4, 5]. Head and
neck paragangliomas (HNPGs) may occur either sporadic-
ally or in the context of a hereditary familial tumor syn-
drome [6]. Multilocular presentations of HNPGs are
observed in 10 to 20 % of sporadic cases and nearly 80 %
of hereditary patients [7]. However, PGs are barely mul-
tiple in origin or seen in multiple organs. Malignant
HNPGs are known to metastasize but typically invade lo-
cally although there are very few case reports showing
metastatic spread of primary HNPGs to the liver. To the
best of our knowledge, the existence of multiple PGs in
head and neck and the liver are extremely rare, which
should be defined as malignant PGs according to the 2004
World Health Organization classification [2, 8, 9]. Unfor-
tunately, no molecular or histologic markers exist to pre-
dict if a primary PG has metastatic potential [1, 2, 8].
Although Stoeckli et al. [10] had reported that not all
HNPGs are highly vascularized, most of these masses
harbor characteristic findings on radiologic imaging,
appearing as well-circumscribed, strongly enhancing
masses [4, 11]. However, preoperative diagnosis of hep-
atic PGs remains a big challenge because hepatic PGs
are often confused with fibrolamellar hepatocellular car-
cinoma [12]. Advanced medical imaging technologies
such as ultrasound (US), computed tomography (CT),
magnetic resonance (MR), digital subtraction angiography
(DSA) and 123I-metaiodobenzylguanidine (123I-MIBG)
may be useful in the evaluation of the patients with PGs.
To date, there are very few literatures describing the
radiologic features of hepatic PGs. Here we report a case
of multiple HNPGs with hepatic PGs and make a short re-
view of the literature related to the radiologic features and
therapeutic strategies of the rarely occurring multiple
tumors.
Case presentation
A 59-year-old man presented with a 40-year history of
an enlarged mass at the right side of the neck and two
months of epigastric discomfort. He denied fatigue,
flushing, heat or cold intolerance, headaches. There was
no abnormality of his familial history related to cancer
or inherited diseases. Neck physical examination revealed
a 6 × 6 cm, ovoid, firm mass on the right side of the neck.
Laboratory evaluation revealed γ-glutamyltransferase 135
(normal range: 10–60 U/L), lactate dehydrogenase 104
(normal range: 109–245 U/L), creatine kinase 14 (normal
range: 38–174 U/L), C-reactive protein 147 (normal range:
0–8 mg/L), D-dimer 12.23 (upper reference limit:
0.55 mg/L). The plasma levels of tumor markers alpha
fetal protein (AFP) and CA199 were within normal limits.
A pre-contrast CT scan of the head and neck revealed
bilateral heterogeneous soft tissue density masses at the
bifurcation of the carotid artery with indistinct border,
the size of which was 2.4 cm × 2.6 cm on the left and
5.4 cm × 4.3 cm on the right. After contrast administra-
tion, the lesions were intensely and heterogeneously en-
hanced with the internal and external carotid arteries
surrounded and pushed anteriorly (Fig. 1a-b). MRI
showed a hyperintense signal on T2 weighted images
compared to the surrounding muscle tissue and an in-
tense contrast enhancement on T1 weighted images
(Fig. 1c). DSA exhibited a highly vascularized masses
that occupied and deformed both sides of the carotid bi-
furcation (Fig. 1d-e). The cardiovascular surgeon classi-
fied bilateral masses as type II in Shamblin classification
[11, 13] and advised embolization and excision of the
right mass, which was performed without complications.
Furthermore, bilateral internal carotid arteries had
undertaken angioplasty and stenting, considering that bi-
lateral masses had shown the vascular invasion. The
postoperative computed tomographic angiography
(CTA) imaging confirmed the scope of operation
(Fig.1f ). Histopathological examination of the surgical
specimen demonstrated that all masses were entirely
covered with fibrous capsules, and its architectural pat-
tern resembled “zellballen” (Fig. 1g-h). The size of the
tumor cells varied and the nuclei of the tumor cells were
round or oval with some tumor cells having large nuclei
or multiple nuclei. Given the histological findings, im-
munohistochemical staining of neuroendocrine markers
was performed to evaluate for possible differentiation.
Synaptophysin was used to identify the chief cells of
neuroendocrine origin whereas S-100 stained the susten-
tacular cells. The neoplastic cells were strongly immuno-
reactive for synaptophysin (Fig. 1i) and outlined by the
supporting sustentacular framework as stained by S-100
protein (Fig. 1j).
Non-contrasted CT imaging of the upper abdomen
showed a 6.1 cm × 5.5 cm × 5.8 cm low density mass in
the liver with indistinct border. On late arterial phase,
the mass showed slightly enhanced with an enlarged
hepatic artery pushed around the lesion (Fig. 2a). MR
imaging of the lesion in the liver demonstrated low sig-
nal intensity on T1 weighted images (Fig. 2b) but hetero-
geneous high signal intensity on T2 weighted images
compared to the liver tissue (Fig. 2c). On diffusion
weighted images, the solid component of the mass
showed high signal intensity whereas low signal intensity
was seen on the image of apparent diffusion coefficient
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(ADC) (Fig. 2d-e). Moreover, the contrast-enhanced
MRI showed the lesion was intensely but heteroge-
neously enhanced (Fig. 2f ). With the hepatic mass sus-
pected as malignant tumor, transcatheter hepatic arterial
chemoembolization was performed, which also con-
firmed the hepatic mass as a highly vascularized tumor
(Fig. 2g). Three months later, a hemihepatectomy was
performed to resect the mass lesion successfully. Histo-
pathological and immunohistochemical study revealed
that the mass contained a similar “Zellballen” pattern of
tumor cells (Fig. 2h-i) and was immunoreactive for synap-
tophysin (Fig. 2j).
The patient recovered with uneventful course after
surgical removal of the tumors and was followed
annually for 8 years without clinical and radiological
signs of recurrence.
Discussion
Paragangliomas are considered to be benign tumors that
arise from paraganglia [14, 15]. They may occur along
the paraganglia’s pathway of embryologic migration from
the skull base to the pelvic floor [5]. The incidence of
head and neck PGs has been reported in a range of
1:30,000 to 1:100,000, comprising only 0.6 % of all head
and neck tumors. Even rarer is multiple HNPGs with
concurrent hepatic PG. To date, most hepatic PGs re-
ported in the literature are considered as liver metastasis
from extra-adrenal PGs since extra-adrenal PGs are
Fig. 1 Radiologic, histologic and immunophenotypic features of HNPGs in the patient. a Coronal contrast enhanced multiple-planner reconstruction
(MPR) image for a better visualization of the relationship between the masses and the carotid artery. Bilateral masses were detected at the bifurcation
of both sides of the carotid artery, showing intense but heterogeneous enhancement with the internal and external carotid arteries surrounded and
pushed anteriorly. b Computed tomographic angiography (CTA) image showing the tumor vascularity. c The axial gadolinium-enhanced T1-weighted
image showing intense enhancement on the masses. d, e Digital subtraction angiography (DSA) showing highly vascularized masses occupying and
deforming the bifurcation of both the right (d) and left (e) side of the carotid artery. f The postoperative CTA image showing the right mass excised
and stent implatation in bilateral internal carotid arteries. g, h Haematoxylin and eosin staining of the HNPG specimen showing the nested (Zellballen)
pattern of neoplastic cells and their neuroendocrine appearance (g: magnification, × 200; h: magnification, × 400). i, j Immunohistochemical staining
for synaptophysin (i) and S-100 (j) highlighting the chief and sustentacular cells, respectively (magnification, × 400)
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associated with a relatively high rate of malignancy, ran-
ging from 14 to 50 % [16]. Malignant HNPGs could
spread both hematogenously and lymphatically with the
most common sites of distant metastases being bone,
liver, and lungs. Metastatic carotid body paraganglioma
(CBPG) involved in the liver was reported to be as few
as 10 cases [9]. In our case, the fact that the patient
had a long history of prior neck mass and the hepatic
lesion showed paraganglioma also points toward the
probability that the hepatic PGs may be metastases of
HNPGs. However, we cannot exclude a possibility
that PGs both in the neck and in the liver developed
separately and all were primary neoplasms. Although
rare, CBPG with other PGs in the neck and thyroid
has been documented [15, 17].
Due to the highly vascular nature of most HNPGs, an
open or closed biopsy should not be attempted [4, 18].
The traditional gold standard for non-invasive diagnosis
of HNPGs is DSA. However, other imaging modalities
such as US, CT, MRI and 123I-MIBG are also necessary
to establish the diagnosis [13, 18, 19]. In regards to the
differentiation between HNPGs and other masses in the
neck, schwannoma and lymphadenopathy should be
taken into consideration. Due to the lack of high vascular-
ity, the enhancement of schwannomas and lymphadenop-
athy are less than HNPGs [4]. Moreover, schwannoma
often makes the internal and external carotid arteries dis-
placing rather than splaying, which is a characteristic find-
ing to differentiate HNPGs from schwannomas [15]. With
respect to hepatic PGs, the diagnosis of this entity usually
depends on pathology after resection or biopsy. There is
no report in the literature regarding utility of advanced
imaging techniques for diagnosis of hepatic PGs. The dif-
ferentiation between hepatic PGs and fibrolamellar hepa-
tocellular carcinomas (HCCs) are really difficult since
hepatic PGs can show significantly enhanced on hepatic
arterial phase as fibrolamellar HCCs do. In this case re-
port, CT imaging revealed that the solid components of
hepatic PGs were significantly enhanced while the nec-
rotic elements displayed a non-enhancement. MRI on the
hepatic PGs demonstrated low signal intensity on T1
weighted images and heterogeneous high signal intensity
on T2 weighted images compared to the normal liver tis-
sue. On gadolinium T1-weighted images, the solid com-
ponents enhanced markedly and heterogeneously whereas
the necrotic elements did not. Interestingly, hepatic PG in
our case demonstrated signal void of vessels in tumors on
T2-weighted images but lacking of central scar in tumors
which is characteristic in fibrolamellar HCCs and probably
a key point for the differentiation. Histologically, hepatic
PG often resemble extra-adrenal PGs at other sites, which
may lead to misdiagnosis of it as other common types of
hepatic neoplasms. Thus, the accurate diagnosis may fur-
ther rely on the immunohistochemical staining on tumor
or tissue-specific markers.
The current treatment options for HNPGs include sur-
gical resection, radiation therapy, permanent embolization
or a combination of those modalities [20]. Surgical resec-
tion has been considered a standard of treatment for
HNPGs and should be offered to patients unless the risk
Fig. 2 Radiologic, histologic and immunophenotypic features of
hepatic PGs in the patient. a Late arterial phase image showing the
slightly enhanced mass. b T1-weighted image exhibiting low signal
intensity of the mass compared to the liver tissue. c T2 weighted
image showing heterogeneous high signal intensity of the mass
compared to the liver tissue. d, e Diffusion weighted image
demonstrating high signal intensity of the solid component in
the mass (d), whereas low signal intensity was seen on the image
of ADC (e). f The contrast-enhanced MRI shows that the mass was
heterogeneously and dramatically enhanced. g DSA showing that
the hepatic mass was highly vascularized. h, i Haematoxylin and
eosin staining of the hepatic PG specimen showing the nested
(Zellballen) pattern of neoplastic cells and their neuroendocrine
appearance (h: magnification, × 200; i: magnification, × 400).
j Immunohistochemical staining for expression of synaptophysin
(magnification, × 200)
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of surgery outweighs its potential benefits [3]. In our
present case, bilateral HNPGs had showed partially
surrounding the vessels, which made radical resection
of both masses in the carotid bifurcation challenging.
Taken all factors into consideration, embolization of
the right mass and following excision will reduce in-
traoperative hemorrhage. Furthermore, bilateral in-
ternal carotid arteries had undertaken angioplasty and
stenting, which may play an important role in pre-
venting invasion. As for multiple HNPGs with hepatic
PGs, because of the rarity clinical trials are not feas-
ible and comparison of treatment outcome from very
few patients reported is not sensible. As a result,
management decisions for such patients are based on
logical assumptions on the characteristics of this
slow-growing pattern of the tumor and the theoretic
benefits of the different treatment modalities [5].
When paragangliomas have metastasized, surgical
eradication of the tumor and its regional confined
lymph nodes would offer the best chance of cure. In
our case, both hepatic mass and the regional lymph
nodes had been completely resected. Although surgi-
cal outcomes for PGs are most favorable, post-
operational and long-term follow-up with CT or MRI
is highly recommended.
Conclusions
In conclusion, multiple HNPGs with hepatic paragan-
glioma are exceedingly rare. Advanced medical imaging
modalities such as US, CT, MR, DSA and 123I-MIBG are
helpful in the evaluation of the patients with PGs. In-
creased awareness of their concomitant occurrence and
familiarity with their characteristic features are critical
for clinicians and radiologists to avoid diagnostic and
therapeutic pitfalls and to facilitate the early diagnosis.
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